MDL | MFCD04113190 |
---|---|
Molecular Weight | 764.00 |
Molecular Formula | C34H68N2O4Pt |
SMILES | NC1CCCCC1N.[O-]C(CCCCCCCCCCCCC)=O.[O-]C(CCCCCCCCCCCCC)=O.[Pt+2] |
Miriplatin (SM-11355) is a chemotherapy agent which belongs to the class of alkylating agents.
Miriplatin (SM-11355) suspended in LPD (miriplatin/LPD, 100 μg/mL) inhibits the growth of AH109A cells, forms platinum-DNA adducts, and induces apoptosis [2] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Miriplatin (SM-11355) (0.02-0.4 mg/20 μL) in lipiodol reduces tumor growth rates in a dose dependent manner in rats bearing AH109A tumor cells [1] . Miriplatin/LPD (400 μg/head) significantly reduces the growth of tumor in rats bearing AH109A cells [2] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
Acetone : < 1 mg/mL (ultrasonic) (insoluble ; DMSO can inactivate Miriplatin's activity)
DMF : < 1 mg/mL (insoluble ; DMSO can inactivate Miriplatin's activity)
H 2 O : < 0.1 mg/mL (insoluble ; DMSO can inactivate Miriplatin's activity)
* Miriplatin is usually formulated as a suspension.